Integrated Biopharma (INBP) Capital Expenditures (2010 - 2026)
Integrated Biopharma's Capital Expenditures came in at $149,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with -$10,000 a year earlier.
Powered by 
Analysis
Integrated Biopharma (INBP) Capital Expenditures (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Integrated Biopharma's Capital Expenditures was $346,000, up 81.2% from FY2025.
- Capital Expenditures carries a five-year compound annual growth rate of 3.2% (FY2021 to FY2026).
- Going back by fiscal year, Capital Expenditures was $191,000 in FY2025 (-65.5%), $553,000 in FY2024 (+376.7%), $116,000 in FY2023 (-76.1%) and $486,000 in FY2022 (+64.7%).
- The five-year range for quarterly Capital Expenditures is -$10,000 (fiscal Q4 2025) to $345,000 (fiscal Q3 2024).
- Year-over-year, Capital Expenditures increased in three of the last five quarters, with growth averaging 38.7%.
- The fastest year-over-year change in Capital Expenditures over five years came in fiscal Q4 2024 (growth of 711.1%), and the weakest in fiscal Q3 2023 (a decline of 88.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Procter & Gamble | 336.76 Bn | 292.75 Bn | 10.28 Bn | 1.02 Bn |
| 2 | Colgate Palmolive | 67.18 Bn | 62.24 Bn | 3.30 Bn | 128.00 Mn |
| 3 | Estee Lauder Companies | 33.32 Bn | 21.40 Bn | 2.74 Bn | 151.00 Mn |
| 4 | Kenvue | 33.09 Bn | 28.70 Bn | 2.30 Bn | 64.00 Mn |
| 5 | Kimberly Clark | 31.38 Bn | 28.71 Bn | 1.60 Bn | 352.00 Mn |
| 6 | Church & Dwight | 22.37 Bn | 20.90 Bn | 693.90 Mn | 29.90 Mn |
| 7 | Clorox | 9.72 Bn | 8.16 Bn | 804.00 Mn | 86.00 Mn |
| 8 | e.l.f. Beauty | 6.17 Bn | 5.15 Bn | 398.84 Mn | 1.43 Mn |
| 9 | Reynolds Consumer Products | 4.71 Bn | 4.37 Bn | 245.00 Mn | 57.00 Mn |
| 10 | Integrated Biopharma | 5.59 Mn | -14.75 Mn | 28,000.00 | 149,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 149,000.00 |
| Dec 31, 2025 | 24,000.00 |
| Sep 30, 2025 | 173,000.00 |
| Jun 30, 2025 | -10,000.00 |
| Mar 31, 2025 | 116,000.00 |
| Dec 31, 2024 | 29,000.00 |
| Sep 30, 2024 | 56,000.00 |
| Jun 30, 2024 | 146,000.00 |
| Mar 31, 2024 | 345,000.00 |
| Dec 31, 2023 | 24,000.00 |
| Sep 30, 2023 | 38,000.00 |
| Jun 30, 2023 | 18,000.00 |
| Mar 31, 2023 | 16,000.00 |
| Dec 31, 2022 | 32,000.00 |
| Sep 30, 2022 | 50,000.00 |
| Jun 30, 2022 | 35,000.00 |
| Mar 31, 2022 | 143,000.00 |
| Dec 31, 2021 | 177,000.00 |
| Sep 30, 2021 | 131,000.00 |
| Jun 30, 2021 | 145,000.00 |
API Access
Integrated Biopharma Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=INBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "INBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=INBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();